Profile data is unavailable for this security.
About the company
Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. It is also involved in the development of value-added products for dermo-cosmetics and the distribution of pharmaceutical products through its subsidiary. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company's cosmeceutical products include R-Spinasome and Purgenesis.
- Revenue in CAD (TTM)5.03m
- Net income in CAD-4.28m
- Incorporated2017
- Employees6.00
- LocationDevonian Health Group Inc360 rue des EntrepreneursMONTMAGNY G5V 4T1CanadaCAN
- Phone+1 (514) 248-7509
- Fax+1 (450) 937-6696
- Websitehttps://groupedevonian.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Covalon Technologies Ltd | 25.07m | -4.93m | 30.83m | -- | -- | 1.72 | -- | 1.23 | -0.1994 | -0.1994 | 1.01 | 0.7163 | 0.9589 | 1.84 | 5.96 | -- | -18.86 | -18.06 | -22.78 | -27.10 | 53.90 | 51.89 | -19.67 | -27.06 | 3.25 | -- | 0.0723 | -- | 46.56 | -0.096 | 51.79 | -- | 12.21 | -- |
Pharmacielo Ltd | 2.81m | -12.82m | 31.40m | 268.00 | -- | 10.79 | -- | 11.17 | -0.082 | -0.082 | 0.018 | 0.0172 | 0.1046 | 1.27 | 18.23 | -- | -47.70 | -- | -67.05 | -- | -7.08 | -- | -456.04 | -- | 0.1712 | -4.01 | 0.8578 | -- | 172.93 | -- | 45.49 | -- | -- | -- |
Thiogenesis Therapeutics Corp | 0.00 | -3.44m | 32.76m | -- | -- | 8.31 | -- | -- | -0.0903 | -0.0903 | 0.00 | 0.0866 | 0.00 | -- | -- | -- | -129.17 | -- | -139.71 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
Medicus Pharma Ltd | 0.00 | -4.20m | 33.99m | -- | -- | 7.05 | -- | -- | -1.03 | -1.03 | 0.00 | 0.2983 | 0.00 | -- | -- | -- | -119.56 | -306.99 | -189.89 | -- | -- | -- | -- | -- | -- | -1.05 | 0.00 | -- | -- | -- | 16.81 | -- | -- | -- |
Medipharm Labs Corp | 33.06m | -13.08m | 34.25m | 166.00 | -- | 0.6437 | -- | 1.04 | -0.0402 | -0.0402 | 0.0992 | 0.132 | 0.5109 | 3.29 | 3.70 | 199,168.70 | -20.22 | -32.88 | -23.98 | -39.56 | 12.06 | -5.88 | -39.57 | -67.66 | 2.46 | -- | 0.0415 | -- | 49.49 | 26.52 | 56.37 | -- | -49.66 | -- |
Avicanna Inc | 16.79m | -8.74m | 35.14m | 38.00 | -- | -- | -- | 2.09 | -0.1026 | -0.1026 | 0.1968 | -0.0012 | 0.8483 | 2.36 | 9.22 | 441,881.10 | -44.17 | -67.17 | -407.35 | -167.73 | 45.38 | 46.36 | -52.07 | -368.82 | 0.3273 | -12.75 | 0.1845 | -- | 314.82 | 169.57 | 40.67 | -- | -32.29 | -- |
Devonian Health Group Inc | 5.03m | -4.28m | 37.06m | 6.00 | -- | 2.79 | -- | 7.36 | -0.0304 | -0.0304 | 0.0352 | 0.0897 | 0.2723 | 16.81 | 3.47 | 838,660.00 | -23.17 | -21.02 | -30.01 | -23.96 | 37.90 | 29.96 | -85.08 | -131.97 | 1.11 | -15.22 | 0.0113 | -- | 1.74 | -5.83 | -33.39 | -- | -- | -- |
Nurexone Biologic Inc | 0.00 | -5.00m | 39.38m | 8.00 | -- | 111.18 | -- | -- | -0.1135 | -0.1135 | 0.00 | 0.0054 | 0.00 | -- | -- | -- | -146.66 | -213.78 | -294.38 | -596.97 | -- | -- | -- | -- | -- | -- | 0.0105 | -- | -- | -- | 55.45 | -- | -- | -- |
Charlotte's Web Holdings Inc | 86.76m | -32.69m | 39.91m | 164.00 | -- | 0.5156 | -- | 0.46 | -0.2147 | -0.2147 | 0.5686 | 0.4946 | 0.3713 | 1.14 | 33.27 | 529,038.60 | -13.99 | -25.71 | -16.13 | -29.03 | 56.32 | 48.98 | -37.68 | -63.11 | 2.40 | -- | 0.4336 | -- | -14.82 | -1.90 | 59.88 | -- | -7.88 | -- |
Medexus Pharmaceuticals Inc | 158.98m | 8.08m | 42.68m | 98.00 | 4.77 | 1.05 | 2.65 | 0.2685 | 0.366 | 0.366 | 7.31 | 1.66 | 0.7547 | 2.19 | 5.44 | 1,622,276.00 | 3.83 | -6.83 | 8.44 | -9.79 | 52.91 | 53.90 | 5.08 | -11.45 | 0.7013 | 0.9426 | 0.6388 | -- | 40.93 | 69.17 | 142.41 | -- | -8.59 | -- |
IntelGenx Technologies Corp. | 1.43m | -13.64m | 43.54m | 48.00 | -- | -- | -- | 30.50 | -0.0781 | -0.0781 | 0.0082 | -0.0963 | 0.1189 | 26.06 | 1.56 | -- | -113.63 | -75.15 | -297.44 | -133.79 | -66.80 | -- | -955.44 | -819.85 | 0.4001 | -5.99 | 5.41 | -- | 9.37 | -10.65 | 7.14 | -- | -30.32 | -- |